Harbin Pharmaceutical Group (600664.SH): Sodium sulfate receives approval for chemical API marketing application.

Zhitong Finance APP News, Harbin Pharmaceutical Group Co., Ltd. (600664.SH) announced that recently, its affiliated enterprise Harbin Pharmaceutical Group Bioengineering Co., Ltd. received the "Chemical Active Pharmaceutical Ingredient Marketing Application Approval Notification" issued by the National Medical Products Administration regarding sodium sulfate.